ACRA RPRX
- - -%
Today share price
Amerika Serikat
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Показатель: 38 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

16.44B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

22.10B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

-
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

446.57M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-
Upcoming events All events
No upcoming events scheduled

Stock chart

Stock analysis

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

Lagi
14.49 -
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

Lagi
2.52 0.78
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

Lagi
14.81 3.81
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

Lagi
3.79 3.79
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

Lagi
17.39 -

Price change per year

34.63$ 52.59$
Min Max

Summary analysis

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure

Revenue and net income

All parameters
Stock news All news

Парламент Турции принял законопроект о продаже СПГ в рамках создания газового хаба - ТВ

На Кубе открылась Международная туристическая ярмарка, участвуют компании более 50 стран

Минцифры предложило штрафы до 2 млн руб. за нарушения при оказании иностранцам услуг связи

В Башкирии создадут импортозамещающее производство фосфорной кислоты

МИНЦИФРЫ ПРЕДЛАГАЕТ ВВЕСТИ ШТРАФЫ В 1-2 МЛН РУБЛЕЙ ДЛЯ ОПЕРАТОРОВ ЗА НАРУШЕНИЕ ТРЕБОВАНИЙ К ОКАЗАНИЮ УСЛУГ МОБИЛЬНОЙ СВЯЗИ ИНОСТРАНЦАМ - ПРОЕКТ

Rostic`s построит четыре ресторана в Башкирии, три из них в Уфе

Кабмин РФ вывел золото из-под действия курсовой экспортной пошлины

«Дивиденды будут, но это не точно». Эксперты о выплатах «Газпрома»

Сбербанк примет участие в проектах по цифровизации в Ленобласти - губернатор

Первые рейсы в Минеральные Воды и Калининград отправились из Кирова

Российские индексы в четверг торговались разнонаправленно

Турпоток из России в Узбекистан вырос более чем в 10 раз за четыре года - МЭР

Есть ли позитивные сигналы для российской экономики

Выручка разработчика ПО "Ред софт" в 2023 г. выросла на 60,4% - до 2,075 млрд руб.

TikTok стал полностью доступен у пользователей в РФ

Базовое судно СПГ-терминала в Клайпеде до середины июня газ принимать не будет

Пожар произошел на установке АВТ-3 Рязанской НПК 1 мая - источники

About company

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 45 marketed therapies and 9 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Address:
110 East 59th Street, New York, NY, United States, 10022
Company name:
Issuer ticker: RPRX
ISIN: GB00BMVP7Y09
Country: Amerika Serikat
Exchange: ACRA
Currency: $
IPO date: 1993-03-25
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.royaltypharma.com

On which stock exchange are (RPRX) stocks traded?

(RPRX) stocks are traded on ACRA.

What is the ticker of stocks (RPRX)?

The stock ticker of ’s stocks or in other words, the code is RPRX. The stocks are currently listed on the ACRA exchange.

In which sector and industry does (RPRX) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, (RPRX) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are (RPRX) stocks traded?

(RPRX) stocks are traded on the ACRA exchange in dollars.

What is the price of (RPRX) stocks today?

The current price of stocks on 03.05.2024 is dollars. per share.

What is the dynamics of (RPRX) stocks from the beginning of the year?

(RPRX) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did (RPRX) stocks increase in мае 2024?

This month (RPRX) quotes have increased by 0% to dollars. per share.

How much are (RPRX) stocks worth?

Today, on October, 03.05.2024 ’s (RPRX) stocks cost dollars..

What is the market capitalization of (RPRX)?

Capitalization is the market value of (RPRX) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 03.05.2024, the market capitalization of (RPRX) is estimated at about 16438199994 dollars.